Australia's most trusted
source of pharma news
Monday, 30 June 2025
Posted 24 May 2024 AM
Novartis Country President ANZ Matt Zeller has underlined the importance of Australia upping its performance in providing broad, fast, equitable access to innovative treatments if it wants to be a player on the international stage.
Speaking at a webinar yesterday titled: Clinical Trials and Tribulations: the Upside of Down Under Zeller praised Australia's impressive research capabilities but delivered some hard truths about limitations hampering the local sector.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.